Citazione APA

Shah, M. A., Bennouna, J., Doi, T., Shen, L., Kato, K., Adenis, A., . . . Enzinger, P. (2021). KEYNOTE-975 study design: A Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma. Future Oncol.

Stile di citazione Chicago

Shah, Manish A., et al. "KEYNOTE-975 Study Design: A Phase III Study of Definitive Chemoradiotherapy Plus Pembrolizumab in Patients With Esophageal Carcinoma." Future Oncol 2021.

Citazione MLA

Shah, Manish A., et al. "KEYNOTE-975 Study Design: A Phase III Study of Definitive Chemoradiotherapy Plus Pembrolizumab in Patients With Esophageal Carcinoma." Future Oncol 2021.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.